Filing Details
- Accession Number:
- 0001127602-15-022862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-15 17:08:15
- Reporting Period:
- 2015-07-14
- Filing Date:
- 2015-07-15
- Accepted Time:
- 2015-07-15 17:08:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235598 | M James Frates | Connaught House 1 Burlington Road Dublin 4 Ireland | Svp & Cfo, Alkermes Plc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-07-14 | 10,000 | $14.38 | 58,713 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2015-07-14 | 10,000 | $11.74 | 68,713 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-07-14 | 11,515 | $65.37 | 57,198 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-07-14 | 8,485 | $66.37 | 48,713 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2015-07-14 | 10,000 | $0.00 | 10,000 | $14.38 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2015-07-14 | 10,000 | $0.00 | 10,000 | $11.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2016-12-12 | No | 4 | M | Direct | |
| 81,983 | 2020-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 4,000 | Indirect | By Sons |
| Ordinary Shares | 50,801 | Indirect | By 2014 GRAT |
| Ordinary Shares | 41,423 | Indirect | By 2015 GRAT |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.87 to $65.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.88 to $66.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held by James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "GRAT"). The Reporting Person is a trustee and beneficiary of the GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the GRAT.
- Shares held by the 2015 GRAT. The Reporting Person is a trustee and beneficiary of the 2015 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2015 GRAT.
- These options are fully vested in accordance with their terms.
Billionaire Hedge Funds
